Nav: Home

Synthetic biology applications face unclear path to market

October 15, 2015

The pathway to market for new products utilizing synthetic biology can be difficult to navigate, posing a challenge for companies in their efforts to commercialize new ideas, while the novelty posed by some of these products can make it difficult for regulatory agencies to evaluate risks, according to a new report from the Synthetic Biology Project.

The report, The DNA of the U.S. Regulatory System: Are We Getting It Right for Synthetic Biology?, explores current government oversight of synthetic biology in the United States by examining the regulatory pathways of different products and applications. The case studies in the report include synthetic organisms, synthetic chemicals, biopesticides, biomining products, and genetically modified plants, which are regulated by the Environmental Protection Agency, Food and Drug Administration and U.S. Department of Agriculture.

This regulatory environment can be particularly challenging for startups in the biotechnology space. While larger companies may have the resources to navigate the various laws, it can be difficult for smaller companies to know which agency to approach and even which laws may apply to particular applications.

"Based on this report, it appears the U.S. regulatory system may need its own genetic engineering," says Dr. Todd Kuiken, senior program associate with the Synthetic Biology Project. "The system is not flexible enough to address rapidly evolving technologies like synthetic biology. This could make it difficult for agencies to properly evaluate the potential risks of these products, as well making it difficult for products to move to the market."

"Our report demonstrates the regulatory complexity innovators face in seeking to commercialize their products," says Lynn Bergeson, lead author of the report and managing partner at Bergeson & Campbell PC. "The report offers some common-sense and easily implemented solutions to help federal agencies do their jobs more efficiently and offers suggestions for the regulated community to be more proactive in expanding the technological literacy of the agencies with jurisdictional oversight over their products."

Government agencies are currently examining how to update the United States' biotechnology regulatory system. The Environmental Protection Agency recently started a process to determine how to best address genetically modified algae, while the White House in July convened a process to evaluate and update the Coordinated Framework for Regulation of Biotechnology, the Reagan-era system for evaluating biotechnology products.

In addition to the full report, each case study is available individually. The full report and set of case studies can be found here: http://www.synbioproject.org/publications/dna-of-the-u.s-regulatory-system/
-end-


About the Synthetic Biology Project


The Synthetic Biology Project is an initiative of the Woodrow Wilson International Center for Scholars supported by a grant from the Alfred P. Sloan Foundation. The Project aims to foster informed public and policy discourse concerning the advancement of synthetic biology. For more information, visit: http://www.synbioproject.org



About The Wilson Center


The Wilson Center provides a strictly nonpartisan space for the worlds of policymaking and scholarship to interact. By conducting relevant and timely research and promoting dialogue from all perspectives, it works to address the critical current and emerging challenges confronting the United States and the world. For more information, visit: http://www.wilsoncenter.org

Woodrow Wilson International Center for Scholars/Science and Technology Innovation Program

Related Synthetic Biology Articles:

Synthetic nanochannels for iodide transport
Iodide channels have the potential to treat thyroid diseases and some types of cancers.
Researchers assemble five new synthetic chromosomes
A global research team has built five new synthetic yeast chromosomes, meaning that 30 percent of a key organism's genetic material has now been swapped out for engineered replacements.
New tool can help policymakers prioritize information needs for synthetic biology tech
New technologies are developed at a rapid pace, often reaching the marketplace before policymakers can determine how or whether they should be governed.
Role of protein engineering techniques in synthetic biology
Proteins are the major biochemical workhorses that carry out multitude of physiological functions in an organism.
Synthetic biology used to limit bacterial growth and coordinate drug release
Researchers have engineered a clinically relevant bacterium to produce cancer drugs and then self-destruct and release the drugs at the site of tumors.
More Synthetic Biology News and Synthetic Biology Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...